BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20827028)

  • 1. Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Kaetsu Y; Mizuta E; Sugihara S; Ishida K; Yanagihara K; Hisatome I; Shigemasa C
    Circ J; 2010 Nov; 74(11):2346-52. PubMed ID: 20827028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.
    Gullestad L; Aukrust P; Ueland T; Espevik T; Yee G; Vagelos R; Frøland SS; Fowler M
    J Am Coll Cardiol; 1999 Dec; 34(7):2061-7. PubMed ID: 10588224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined renin-angiotensin system-inhibition therapy: what really accounts for the additive benefits?
    Sanada S; Kitakaze M
    Circ J; 2010 Nov; 74(11):2288-9. PubMed ID: 20962426
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
    Watz R; Ekstrand AB; Engelbrektson V; Beermann B
    Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
    Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
    Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M; Tylicki L; Rutkowski P; Rutkowski B
    Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure.
    Ogino K; Kinugasa Y; Kato M; Yamamoto K; Hisatome I; Anker SD; Doehner W
    Int J Cardiol; 2014 Feb; 171(3):398-403. PubMed ID: 24405838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.
    White M; Lepage S; Lavoie J; De Denus S; Leblanc MH; Gossard D; Whittom L; Racine N; Ducharme A; Dabouz F; Rouleau JL; Touyz R
    J Card Fail; 2007 Mar; 13(2):86-94. PubMed ID: 17395047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin type-1 receptor blockade with losartan increases insulin sensitivity and improves glucose homeostasis in subjects with type 2 diabetes and nephropathy.
    Jin HM; Pan Y
    Nephrol Dial Transplant; 2007 Jul; 22(7):1943-9. PubMed ID: 17308317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
    Kuwabara Y; Komuro I
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):255-61. PubMed ID: 15768589
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Guazzi M; Melzi G; Agostoni P
    Am J Cardiol; 1997 Dec; 80(12):1572-6. PubMed ID: 9416938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
    Jilma B; Li-Saw-Hee FL; Wagner OF; Beevers DG; Lip GY
    Clin Sci (Lond); 2002 Aug; 103(2):131-6. PubMed ID: 12149103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
    Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
    Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
    Davie AP; Dargie HJ; McMurray JJ
    Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.